English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/71541
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Lafora disease due to EPM2B mutations: A clinical and genetic study

AuthorsGómez-Abad, Cristina; Gómez-Garre, Pilar; Gutiérrez-Delicado, Eva; Saygi, Serap SütÇü; Michelucci, Roberto; Tassinari, Carlo Alberto; Rodríguez de Córdoba, Santiago ; Serratosa, José María
Issue Date2005
PublisherAmerican Academy of Neurology
CitationNeurology 64(6):982-986(2005)
AbstractObjective: To study EPM2B gene mutations and genotype-phenotype correlations in patients with Lafora disease. Methods: The authors performed a clinical and mutational analysis of 25 patients, from 23 families, diagnosed with Lafora disease who had not shown mutations in the EPM2A gene. Results: The authors identified 18 mutations in EPM2B, including 12 novel mutations: 4 nonsense mutations (R265X, C26X, W219X, and E67X), a 6-base pair (bp) microdeletion resulting in a two amino acid deletion (V294_K295del), a 4-bp insertion resulting in a frameshift mutation (S339fs12), and 6 missense mutations (D308A, I198N, C68Y, E67Q, P264H, and D233A). In our data set of 77 families with Lafora disease, 54 (70.1%) tested probands have mutations in EPM2A, 21 (27.3%) in EPM2B, and 2 (2.6%) have no mutations in either gene. The course of the disease was longer in patients with EPM2B mutations vs patients with EPM2A mutations. Conclusions: Genetic allelic heterogeneity is present in Lafora disease associated with mutations in EPM2B. Patients with mutations in EPM2A and EPM2B express similar clinical manifestation, although patients with EPM2B-associated Lafora disease seem to have a slightly milder clinical course. The lack of mutations in EPM2A and EPM2B in two families could be because of the presence of mutations in noncoding, nontested regions or the existence of an additional gene associated with Lafora disease.
Description5 p.-2 tab.
Publisher version (URL)http://dx.doi.org/10.1212/01.WNL.0000154519.10805.F7
URIhttp://hdl.handle.net/10261/71541
DOI10.1212/01.WNL.0000154519.10805.F7
ISSN0028-3878
E-ISSN1526-632X
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Neurology_de Córdoba_2005.pdf861,86 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.